[Edaily Reporter SONG YOUNG-DOO ] ST Pharm Co., Ltd.(237690)has signed a supply contract worth $7.99 million (approximately 11.9 billion won) with a major European pharmaceutical company for active pharmaceutical ingredients (APIs) for small-molecule new drugs.

According to a company announcement on the 15th, this supply contract covers the first shipment of active pharmaceutical ingredients for a new small-molecule drug in 2027, with a delivery date of October 22, 2027. Details such as the drug’s indications will not be disclosed due to a confidentiality agreement with the client.

Sales of this product are expected to exceed 30 billion won this year.

ST Pharm Co., Ltd. currently has a $353.86 million (approximately 530.8 billion won) order backlog, surpassing the 500 billion won mark and representing a 58.7% increase compared to the $223 million order backlog at the end of last year.